elx-02
·Code: NB124
elx-02: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | Phase 2 |
Clinical Trials (1)
A Phase 2 Open Label Pilot Study to Evaluate the Safety and Efficacy of Subcutaneously Administered ELX-02 in Patients With Alport Syndrome With Col4A5 and Col4A3/4 Nonsense Mutation
Frequently asked questions
Who is developing elx-02?
elx-02 is being developed by Eloxx Pharmaceuticals, Inc..
How many clinical trials involve elx-02?
BioSniper tracks 1 clinical trial involving elx-02.
Get deeper analysis on elx-02
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis